doi: 10.1016/s0005-8165(74)80069-7.
A clinical trial of autogenous vaccines in the treatment of osteogenic sarcoma
- PMID: 4529239
- DOI: 10.1016/s0005-8165(74)80069-7
Item in Clipboard
A clinical trial of autogenous vaccines in the treatment of osteogenic sarcoma
Beitr Pathol.
1974 Oct.
No abstract available
Similar articles
-
Proceedings: Clinical trial of autogenous tumor vaccine for treatment of osteogenic sarcoma.Proc Natl Cancer Conf. 1972;7:91-100. Proc Natl Cancer Conf. 1972. PMID: 4550059 No abstract available.
-
Osteogenic sarcoma.Surg Gynecol Obstet. 1973 Mar;136(3):359-66. Surg Gynecol Obstet. 1973. PMID: 4510918 No abstract available.
-
Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment.Cancer Treat Rep. 1978 Feb;62(2):213-6. Cancer Treat Rep. 1978. PMID: 346209 Clinical Trial.
-
[Recent aspects of osteosarcoma therapy].Dtsch Med Wochenschr. 1976 Feb 13;101(7):251-8. doi: 10.1055/s-0028-1104072. Dtsch Med Wochenschr. 1976. PMID: 765088 Review. German. No abstract available.
-
The therapy of osteogenic sarcoma: current status and thoughts for the future.J Surg Oncol. 1972;4(5):482-510. doi: 10.1002/jso.2930040512. J Surg Oncol. 1972. PMID: 4566220 Review. No abstract available.
Cited by
-
Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5.Cancer Sci. 2006 Dec;97(12):1374-80. doi: 10.1111/j.1349-7006.2006.00317.x. Epub 2006 Sep 21. Cancer Sci. 2006. PMID: 16995877 Free PMC article.
-
A quest for therapeutic antigens in bone and soft tissue sarcoma.J Transl Med. 2005 Aug 8;3:31. doi: 10.1186/1479-5876-3-31. J Transl Med. 2005. PMID: 16086842 Free PMC article.